EP2526961A1 - Treating or ameliorating some neuroendocrine ...,https://www.google.com/patents/EP2526961A1?cl=ko
WO2016162675A1 - Compositions th√©rapeutiques et leurs ...,https://www.google.com/patents/WO2016162675A1?cl=fr
US20150150840A1 - Methods of Treating Hypothalamic Obesity ...,http://www.google.com/patents/US20150150840
US20150202291A1 - Combinations of checkpoint inhibitors and ...,https://www.google.com/patents/US20150202291
US20090197796A1 - Methods for treating and preventing cancers ...,http://www.google.com/patents/US20090197796
US20040005304A1 - Novel compositions and methods for treating ...,https://www.google.com/patents/US20040005304
WO2017059177A2 - Enhanced gene delivery to natural killer cells ...,https://www.google.com/patents/WO2017059177A2?cl=en
WO2014093354A1 - Fusion of human growth hormone and albumin ...,https://www.google.com/patents/WO2014093354A1?cl=ru
WO2015015301A2 - Cancer therapy with silver nanoparticles ...,https://www.google.com/patents/WO2015015301A2
US8231856B2 - Chlorite formulations and methods of preparation ...,https://www.google.com/patents/US8231856
